| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 2,315,200 | 2,171,900 | 1,839,800 | | Cost of Revenue | 219,100 | 206,900 | 216,600 | | | Gross Profit | 2,096,100 | 1,965,000 | 1,623,200 | | | Operating Expenses | | Research Development | 576,100 | 485,300 | 406,300 | | Selling General and Administrative | 1,106,400 | 1,034,100 | 867,200 | | Non Recurring | 169,100 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 244,500 | 445,600 | 349,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,000 | 24,400 | 23,200 | | Earnings Before Interest And Taxes | 252,500 | 470,000 | 368,600 | | Interest Expense |
-
|
-
| 2,100 | | Income Before Tax | 252,500 | 470,000 | 366,500 | | Income Tax Expense | 68,900 | 113,800 | 76,800 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 183,600 | 356,200 | 289,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 183,600 | 356,200 | 289,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $183,600 | $356,200 | $289,700 |
|
1.48% Nasdaq 
Income Statement
